- Home
- NFBK vs CTKB Comparison
NFBK vs CTKB Comparison
Compare NFBK & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NFBK | CTKB |
|---|---|---|
| Founded | 1887 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 568.8M | 595.2M |
| IPO Year | 2010 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NFBK | CTKB |
|---|---|---|
| Price | $13.97 | $4.55 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 4 |
| Target Price | ★ $13.50 | $5.63 |
| AVG Volume (30 Days) | 205.3K | ★ 482.7K |
| Earning Date | 04-20-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.73% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | $6,870,000.00 | ★ $193,015,000.00 |
| Revenue This Year | $4.95 | $5.42 |
| Revenue Next Year | $6.32 | $7.03 |
| P/E Ratio | $697.75 | ★ N/A |
| Revenue Growth | 6.84 | ★ 17.67 |
| 52 Week Low | $9.91 | $2.37 |
| 52 Week High | $14.20 | $6.18 |
Technical Indicators
Market Signals| Indicator | NFBK | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 56.83 | 52.34 |
| Support Level | $13.52 | $4.56 |
| Resistance Level | $14.09 | $4.80 |
| Average True Range (ATR) | 0.20 | 0.19 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 63.24 | 74.22 |
Price Performance
Historical ComparisonAbout NFBK Northfield Bancorp Inc. (Delaware)
Northfield Bancorp Inc is the holding company for Northfield Bank. Its subsidiary provides banking services to individuals and corporate customers in Richmond and Kings Counties in New York, and Hunterdon, Mercer, Union, and Middlesex counties in New Jersey. The bank attracts deposits and offers credit and other banking services.
About CTKB Cytek Biosciences Inc.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.